Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage
Disruption of the intestinal epithelial barrier allows bacterial translocation and predisposes to destructive inflammation. To ensure proper barrier composition, crypt-residing stem cells continuously proliferate and replenish all intestinal epithelial cells within days. As a consequence of this hig...
| Κύριοι συγγραφείς: | , , , , , , , , , , |
|---|---|
| Μορφή: | Journal article |
| Γλώσσα: | English |
| Έκδοση: |
Rockefeller University Press
2015
|
| _version_ | 1826270702781595648 |
|---|---|
| author | Aparicio-Domingo, P Romera-Hernandez, M Karrich, J Cornelissen, F Papazian, N Lindenbergh-Kortleve, D Butler, J Boon, L Coles, M Samsom, J Cupedo, T |
| author_facet | Aparicio-Domingo, P Romera-Hernandez, M Karrich, J Cornelissen, F Papazian, N Lindenbergh-Kortleve, D Butler, J Boon, L Coles, M Samsom, J Cupedo, T |
| author_sort | Aparicio-Domingo, P |
| collection | OXFORD |
| description | Disruption of the intestinal epithelial barrier allows bacterial translocation and predisposes to destructive inflammation. To ensure proper barrier composition, crypt-residing stem cells continuously proliferate and replenish all intestinal epithelial cells within days. As a consequence of this high mitotic activity, mucosal surfaces are frequently targeted by anticancer therapies, leading to dose-limiting side effects. The cellular mechanisms that control tissue protection and mucosal healing in response to intestinal damage remain poorly understood. Type 3 innate lymphoid cells (ILC3s) are regulators of homeostasis and tissue responses to infection at mucosal surfaces. We now demonstrate that ILC3s are required for epithelial activation and proliferation in response to small intestinal tissue damage induced by the chemotherapeutic agent methotrexate. Multiple subsets of ILC3s are activated after intestinal tissue damage, and in the absence of ILC3s, epithelial activation is lost, correlating with increased pathology and severe damage to the intestinal crypts. Using ILC3-deficient Lgr5 reporter mice, we show that maintenance of intestinal stem cells after damage is severely impaired in the absence of ILC3s or the ILC3 signature cytokine IL-22. These data unveil a novel function of ILC3s in limiting tissue damage by preserving tissue-specific stem cells. |
| first_indexed | 2024-03-06T21:44:59Z |
| format | Journal article |
| id | oxford-uuid:4943e4cf-91a5-4d27-86ea-db4c88d31403 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:44:59Z |
| publishDate | 2015 |
| publisher | Rockefeller University Press |
| record_format | dspace |
| spelling | oxford-uuid:4943e4cf-91a5-4d27-86ea-db4c88d314032022-03-26T15:30:35ZType 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damageJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4943e4cf-91a5-4d27-86ea-db4c88d31403EnglishSymplectic Elements at OxfordRockefeller University Press2015Aparicio-Domingo, PRomera-Hernandez, MKarrich, JCornelissen, FPapazian, NLindenbergh-Kortleve, DButler, JBoon, LColes, MSamsom, JCupedo, TDisruption of the intestinal epithelial barrier allows bacterial translocation and predisposes to destructive inflammation. To ensure proper barrier composition, crypt-residing stem cells continuously proliferate and replenish all intestinal epithelial cells within days. As a consequence of this high mitotic activity, mucosal surfaces are frequently targeted by anticancer therapies, leading to dose-limiting side effects. The cellular mechanisms that control tissue protection and mucosal healing in response to intestinal damage remain poorly understood. Type 3 innate lymphoid cells (ILC3s) are regulators of homeostasis and tissue responses to infection at mucosal surfaces. We now demonstrate that ILC3s are required for epithelial activation and proliferation in response to small intestinal tissue damage induced by the chemotherapeutic agent methotrexate. Multiple subsets of ILC3s are activated after intestinal tissue damage, and in the absence of ILC3s, epithelial activation is lost, correlating with increased pathology and severe damage to the intestinal crypts. Using ILC3-deficient Lgr5 reporter mice, we show that maintenance of intestinal stem cells after damage is severely impaired in the absence of ILC3s or the ILC3 signature cytokine IL-22. These data unveil a novel function of ILC3s in limiting tissue damage by preserving tissue-specific stem cells. |
| spellingShingle | Aparicio-Domingo, P Romera-Hernandez, M Karrich, J Cornelissen, F Papazian, N Lindenbergh-Kortleve, D Butler, J Boon, L Coles, M Samsom, J Cupedo, T Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage |
| title | Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage |
| title_full | Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage |
| title_fullStr | Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage |
| title_full_unstemmed | Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage |
| title_short | Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage |
| title_sort | type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage |
| work_keys_str_mv | AT apariciodomingop type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage AT romerahernandezm type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage AT karrichj type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage AT cornelissenf type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage AT papaziann type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage AT lindenberghkortleved type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage AT butlerj type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage AT boonl type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage AT colesm type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage AT samsomj type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage AT cupedot type3innatelymphoidcellsmaintainintestinalepithelialstemcellsaftertissuedamage |